Please Wait...

WebHeart Platform

WebHeart is a proprietary, web-based, validated, 21 CFR part 11 compliant and configurable platform for the management, processing, analysis and reporting of cardiovascular safety and efficacy data including ECG and hemodynamic endpoints. Access to cardiac safety data in real time via WebHeart enables rapid and informed decision making for your clinical trial.

Benefits of conducting your study within the WebHeart platform include:

  • Rapid and real-time management of study data via secure internet access
  • Configurable for sponsor-specific protocols
  • Compatibility with all ECG and ABPM technologies and operating systems
  • Centralized storage of cardiovascular data from both single center early phase trials to multicenter global studies
  • Role-based, 'rights-restricted' security model
  • Regulatory submission-ready ECG data
  • No special software, plug-ins, or add-ons required

Data Integrity and Security

WebHeart and associated processes have been developed and are continually enhanced to provide our sponsors with credible trial data that has been evaluated and managed within rigorous quality systems. WebHeart is 21CFR part 11 compliant and has successfully completed multiple external system audits. Disaster recovery and other data security considerations are built in to the platform and our SOPs.

Data Management and Analysis

One of WebHeart's principal features is a world class ECG processing system offering a complete solution for acquiring, displaying, measuring, and managing ECG data and is compatible with all collection sources (standard, hardcopy, and Holter extractions). WebHeart's primary function is to acquire, store, and display digital ECG images for cardiologist review, fiducial marker identification, interval measurements, findings entry, and image annotation. The system's capabilities include data management, scanning and digitization, audit trail maintenance, security functions, and provide digital ECG data for regulatory submission (FDA, EMA, PMDA, and CFDA).

Study Management

Throughout the course of a study, the Bioclinica study team uses WebHeart as the foundation for study tracking and reporting. All study related items (e.g. calls, open DCFs, closed DCFs, site trainings, site shipments, regulatory documents, etc.) are tracked in WebHeart® and can be continually exported for submission to the project team.

The WebHeart® system provides the following Study Management benefits:

  • Real-time access to study data and trial status
  • Continuous QA monitoring and reporting
  • Multi-layered security, using encryption, digital certificates, user, context, and role-based access control, and detailed auditing to ensure data safety and integrity
  • MCC metrics reporting based on sponsor specifications

ADDITIONAL RESOURCES

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Bioclinica is organized into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging & Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Molecular Marker Laboratory. Our eHealth segment comprises eClinical Solutions, Randomization & Trial Supply Management, Safety & Regulatory Solutions, and Financial Lifecycle Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

Conducting Lymphoma ClinicalTrials? Lugano 2014 criteria for assessing FDG-PET/CT. An operational appch https://t.co/x5bdpI8jUI
bioclinica (52 minutes ago)
ICYMI: Clean Patient Optics: helping #ClinicalResearch teams meet or beat database lock. News https://t.co/pUem5e2cMG
bioclinica (1 hour ago)
Our Medical Imaging team is in the spotlight for a job well done! https://t.co/fkmt0zvPhf https://t.co/D7YMTeiSd3
bioclinica (2 days ago)
RT @melfass: "What this agreement means is that we can allocate scarce resources to areas of higher risk" @US_FDA on MRA with @EMA_News at…
bioclinica (3 days ago)
RT @DrugInfoAssn: What has been the biggest takeway for your organization so far? Tweet @ us using #DIA2017
bioclinica (5 days ago)
"Q" on #RBM & Total Quality Mgmt? @Kristin_Mauri has "A" @DrugInfoAssn #DIA2017 https://t.co/MqCxkmAfa0
bioclinica (5 days ago)

Latest Blogs: